Evidence map›Paper›PMID 32314689›Full record

ArticleThe American journal of tropical medicine and hygiene2020

Epidemiology and Prognosis of Intensive Care Unit-Acquired Bloodstream Infection.

Hatem Kallel, Stephanie Houcke, Dabor Resiere, Michaella Roy, Claire Mayence, Cyrille Mathien, Joy Mootien, Magalie Demar, Didier Hommel, Felix Djossou

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Rebound Inverts theAntibiotics (Basel, Switzerland) · 2024
    Article
  11. Article
  12. CTX-M, TEM, and SHV Genes inInfection and drug resistance · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Antimicrobial Resistance ofJournal of clinical medicine · 2022
    Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hatem Kallel1Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana.
Stephanie Houcke1Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana.
Dabor Resiere2Intensive Care Unit, Martinique University Hospital, Fort-de-France, Martinique.
Michaella Roy1Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana.
Claire Mayence1Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana.
Cyrille Mathien1Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana.
Joy Mootien3Intensive Care Unit, GHRSMA, Mulhouse, France.
Magalie Demar4Laboratory of Microbiology, Cayenne General Hospital, Cayenne, French Guiana.
Didier Hommel1Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana.
Felix Djossou5Tropical and Infectious Diseases Department, Cayenne General Hospital, Cayenne, French Guiana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intensive care unit-acquired bloodstream infections (ICU-BSI) are frequent and are associated with high morbidity and mortality rates. We conducted this study to describe the epidemiology and the prognosis of ICU-BSI in our ICU and to search for factors associated with mortality at 28 days. For this, we retrospectively studied ICU-BSI in the ICU of the Cayenne General Hospital, from January 2013 to June 2019. Intensive care unit-acquired bloodstream infections were diagnosed in 9.5% of admissions (10.3 ICU-BSI/1,000 days). The median delay to the first ICU-BSI was 9 days. The ICU-BSI was primitive in 44% of cases and secondary to ventilator-acquired pneumonia in 25% of cases. The main isolated microorganisms were Enterobacteriaceae in 67.7% of patients. They were extended-spectrum beta-lactamase (ESBL) producers in 27.6% of cases. Initial antibiotic therapy was appropriate in 65.1% of cases. Factors independently associated with ESBL-producing Enterobacteriaceae (ESBL-PE) as the causative microorganism of ICU-BSI were ESBL-PE carriage before ICU-BSI (odds ratio [OR]: 7.273; 95% CI: 2.876-18.392;

Indexed as

Drug Resistance, Multiple, BacterialAdultAnti-Bacterial AgentsBacteremiaCandidemiaCarrier StateCatheterization, Central VenousCatheterization, PeripheralCatheter-Related InfectionsComaComorbidityCross InfectionEnterobacteriaceae InfectionsFemaleFrench GuianaHumansAnti-Bacterial Agents

Identifiers

PMID32314689
PMCPMC7356483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.